TRENDS AND PROSPECTS IN MEDICINAL AND PHARMA BIOTECHNOLOGIES IN EUROPE

Expected outcomes

  • Increased awareness and sharing of knowledge and experience on the key issues of pharma and medicinal biotechnologies and biobased industry, relevant to RIS3 strategy.
  • Briefing on the new technologies and their potential role to improve bioeconomy in the field of pharma and medicinal biotechnology and related industry.
  • Draft plan of join follow-up initiatives oriented on cooperative projects relevant to upcoming FP9 EC program period 2021-2027 discussed and drafted
  • Regional CEE network including research institutions and innovative high-tech companies in Med/Pharm BT constituted.